Skip to content
OpenCapital
Get started

HealthEquity HQY Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Upper Range Limit, Outstanding

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit, outstanding.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit, outstanding?
HealthEquity (HQY) reported share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit, outstanding of $73.61 in Q1 2026.
How has HealthEquity's share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit, outstanding changed year-over-year?
HealthEquity's share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit, outstanding decreased by 0.0% year-over-year, from $73.61 to $73.61.
What is the long-term trend for HealthEquity's share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit, outstanding?
Over 5 years (2021 to 2026), HealthEquity's share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit, outstanding has grown at a -2.2% compound annual growth rate (CAGR), from $82.39 to $73.61.